TNFSF11 and type 1 diabetes mellitus: After 10 weeks of CS or metformin administration, the bone OPG and RUNX 2 levels increased (CS or Met group vs. T1DM group, p < 0.01) and the RANKL level decreased (CS or Met vs. T1DM group, p < 0.01) (Figures 9A–C).